141 related articles for article (PubMed ID: 27299303)
1. Fluid Intake and Vasopressin: Connecting the Dots.
Guelinckx I; Vecchio M; Perrier ET; Lemetais G
Ann Nutr Metab; 2016; 68 Suppl 2():6-11. PubMed ID: 27299303
[TBL] [Abstract][Full Text] [Related]
2. Relevance of Assessment Methods for Fluid Intake.
Gandy J; Martinez H; Guelinckx I; Moreno LA; Bardosono S; Salas-Salvadó J; Kavouras SA
Ann Nutr Metab; 2016; 68 Suppl 2():1-5. PubMed ID: 27300809
[TBL] [Abstract][Full Text] [Related]
3. The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention.
Enhörning S; Melander O
Ann Nutr Metab; 2018; 72 Suppl 2():21-27. PubMed ID: 29925066
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin, from Regulator to Disease Predictor for Diabetes and Cardiometabolic Risk.
Melander O
Ann Nutr Metab; 2016; 68 Suppl 2():24-8. PubMed ID: 27299865
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin and Diabetic Kidney Disease.
El Boustany R
Ann Nutr Metab; 2018; 72 Suppl 2():17-20. PubMed ID: 29925069
[TBL] [Abstract][Full Text] [Related]
6. A Journey through the Early Evidence Linking Hydration to Metabolic Health.
Vanhaecke T; Perrier ET; Melander O
Ann Nutr Metab; 2020; 76 Suppl 1():4-9. PubMed ID: 33774620
[TBL] [Abstract][Full Text] [Related]
7. Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus.
Villela-Torres ML; Higareda-Mendoza AE; Gómez-García A; Alvarez-Paredes AR; García-López E; Stenvikel P; Gu HF; Rashid-Qureshi A; Lindholm B; Alvarez-Aguilar C
Arch Med Res; 2018 Jan; 49(1):36-43. PubMed ID: 29665969
[TBL] [Abstract][Full Text] [Related]
8. Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort.
Meijer E; Bakker SJ; Halbesma N; de Jong PE; Struck J; Gansevoort RT
Kidney Int; 2010 Jan; 77(1):29-36. PubMed ID: 19847155
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
[TBL] [Abstract][Full Text] [Related]
10. Modifiable factors associated with copeptin concentration: a general population cohort.
van Gastel MD; Meijer E; Scheven LE; Struck J; Bakker SJ; Gansevoort RT
Am J Kidney Dis; 2015 May; 65(5):719-27. PubMed ID: 25500109
[TBL] [Abstract][Full Text] [Related]
11. Association of Copeptin, a Surrogate Marker of Arginine Vasopressin, with Decreased Kidney Function in Sugarcane Workers in Guatemala.
Butler-Dawson J; Dally M; Johnson RJ; Johnson EC; Krisher L; Sánchez-Lozada LG; Griffin BR; Brindley S; Newman LS
Ann Nutr Metab; 2020; 76(1):30-36. PubMed ID: 32172243
[TBL] [Abstract][Full Text] [Related]
12. Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.
Sontrop JM; Huang SH; Garg AX; Moist L; House AA; Gallo K; Clark WF
BMJ Open; 2015 Nov; 5(11):e008634. PubMed ID: 26603245
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin and diabetic nephropathy.
Roussel R; Velho G; Bankir L
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):311-318. PubMed ID: 28403013
[TBL] [Abstract][Full Text] [Related]
14. High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation.
Brunkwall L; Ericson U; Nilsson PM; Enhörning S
Eur J Nutr; 2020 Dec; 59(8):3715-3722. PubMed ID: 32072267
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
[TBL] [Abstract][Full Text] [Related]
16. Shifting Focus: From Hydration for Performance to Hydration for Health.
Perrier ET
Ann Nutr Metab; 2017; 70 Suppl 1():4-12. PubMed ID: 28614817
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing Low and High Water Consumers-A Paradigm of Disease Risk.
Armstrong LE; Muñoz CX; Armstrong EM
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32210168
[TBL] [Abstract][Full Text] [Related]
18. Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot Study.
Enhörning S; Brunkwall L; Tasevska I; Ericson U; Persson Tholin J; Persson M; Lemetais G; Vanhaecke T; Dolci A; Perrier ET; Melander O
J Clin Endocrinol Metab; 2019 Jun; 104(6):1917-1925. PubMed ID: 30566641
[TBL] [Abstract][Full Text] [Related]
19. Water intake keeps type 2 diabetes away? Focus on copeptin.
Muscogiuri G; Barrea L; Annunziata G; Vecchiarini M; Orio F; Di Somma C; Colao A; Savastano S
Endocrine; 2018 Nov; 62(2):292-298. PubMed ID: 30027433
[TBL] [Abstract][Full Text] [Related]
20. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States.
Balanescu S; Kopp P; Gaskill MB; Morgenthaler NG; Schindler C; Rutishauser J
J Clin Endocrinol Metab; 2011 Apr; 96(4):1046-52. PubMed ID: 21289257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
